PMDA — authorised 20 January 2022
- Marketing authorisation holder: AMGEN K.K.
- Status: approved
🇯🇵 Lumakras in Japan
PMDA authorised Lumakras on 20 January 2022
Marketing authorisation
Lumakras in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Lumakras approved in Japan?
Yes. PMDA authorised it on 20 January 2022.
Who is the marketing authorisation holder for Lumakras in Japan?
AMGEN K.K. holds the Japanese marketing authorisation.